A Fuertes

781 total citations
26 papers, 548 citations indexed

About

A Fuertes is a scholar working on Hepatology, Epidemiology and Transplantation. According to data from OpenAlex, A Fuertes has authored 26 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 14 papers in Epidemiology and 6 papers in Transplantation. Recurrent topics in A Fuertes's work include Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (9 papers) and Liver Disease and Transplantation (6 papers). A Fuertes is often cited by papers focused on Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (9 papers) and Liver Disease and Transplantation (6 papers). A Fuertes collaborates with scholars based in Spain. A Fuertes's co-authors include J.M. Morales, José L. Rodicio, Francisco Colina, Josep M. Campistol, Manuel Praga, Amado Andrés, Carlos Lumbreras, Carmelo Loinaz, I González-Pinto and Giuseppe Castellano and has published in prestigious journals such as Clinical Infectious Diseases, Gut and Journal of the American Society of Nephrology.

In The Last Decade

A Fuertes

23 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Fuertes Spain 12 410 337 133 68 49 26 548
C. Fretz France 13 766 1.9× 713 2.1× 140 1.1× 54 0.8× 119 2.4× 20 935
Hugo Wéclawiak France 12 294 0.7× 176 0.5× 54 0.4× 52 0.8× 167 3.4× 21 506
Michael I. Abecassis United States 7 304 0.7× 335 1.0× 61 0.5× 293 4.3× 13 0.3× 11 610
Ingrid Keur Netherlands 7 188 0.5× 170 0.5× 22 0.2× 54 0.8× 34 0.7× 9 305
Ellen Holter Norway 12 196 0.5× 435 1.3× 71 0.5× 168 2.5× 86 1.8× 18 629
J. Rakela United States 10 321 0.8× 280 0.8× 23 0.2× 80 1.2× 33 0.7× 24 401
Marc Deschênes Canada 7 312 0.8× 362 1.1× 82 0.6× 129 1.9× 176 3.6× 17 511
S. Tamura Japan 13 177 0.4× 151 0.4× 61 0.5× 209 3.1× 102 2.1× 27 391
Anthony I. Sahyoun United States 7 39 0.1× 102 0.3× 102 0.8× 92 1.4× 92 1.9× 12 323
Nancy L. Ascher United States 8 834 2.0× 689 2.0× 95 0.7× 200 2.9× 41 0.8× 9 924

Countries citing papers authored by A Fuertes

Since Specialization
Citations

This map shows the geographic impact of A Fuertes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Fuertes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Fuertes more than expected).

Fields of papers citing papers by A Fuertes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Fuertes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Fuertes. The network helps show where A Fuertes may publish in the future.

Co-authorship network of co-authors of A Fuertes

This figure shows the co-authorship network connecting the top 25 collaborators of A Fuertes. A scholar is included among the top collaborators of A Fuertes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Fuertes. A Fuertes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abradelo, M., A Fuertes, Alejandro Manrique, et al.. (2012). Liver Transplantation from Anti-Hepatitis C Virus-Positive Donors: Our Experience. Transplantation Proceedings. 44(6). 1475–1478. 17 indexed citations
2.
Sanfélix‐Genovés, José, Gabriel Sanfélix‐Gimeno, Salvador Peiró, et al.. (2012). Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort. Osteoporosis International. 24(3). 1045–1055. 32 indexed citations
3.
Morales, J.M., Josep M. Campistol, Beatriz Domínguez‐Gil, et al.. (2010). Long-Term Experience With Kidney Transplantation From Hepatitis C-Positive Donors Into Hepatitis C-Positive Recipients. American Journal of Transplantation. 10(11). 2453–2462. 79 indexed citations
4.
Santos, Ernestina, et al.. (2007). Behçet’s disease and Chiari’s network. Clinical Rheumatology. 26(12). 2189–2190. 3 indexed citations
5.
Loinaz, Carmelo, Carlos Lumbreras, E. Moreno, et al.. (2002). Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.. PubMed. 48(41). 1435–42. 5 indexed citations
6.
Tomas, Myreen, et al.. (2002). Viral load and HCV genotypes in renal transplant recipients. Journal of Hepatology. 36. 248–249. 1 indexed citations
7.
Delgado, Juan F., Carolina Ibarrola, Francisco Colina, et al.. (1999). Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor?. The Journal of Heart and Lung Transplantation. 18(6). 607–610. 22 indexed citations
8.
Ibarrola, Carolina, Francisco Colina, Giancarlo Castellano, et al.. (1998). Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients.. Journal of the American Society of Nephrology. 9(6). 1109–1113. 42 indexed citations
9.
Lumbreras, Carlos, Francisco Colina, Carmelo Loinaz, et al.. (1998). Clinical, Virological, and Histologic Evolution of Hepatitis C Virus Infection in Liver Transplant Recipients. Clinical Infectious Diseases. 26(1). 48–55. 11 indexed citations
10.
Morales, Jorge, Axel Andrès, Josep M. Campistol, et al.. (1998). TRANSPLANTATION OF KIDNEYS FROM DONORS WITH HEPATITIS C ANTIBODY INTO HCV RNA POSITIVE RECIPIENTS. A GOOD ALTERNATIVE TO USE THESE ORGANS.. Transplantation. 65(Supplement). 262–262. 1 indexed citations
11.
Morales, J.M., Josep M. Campistol, Amado Andrés, et al.. (1997). MEMBRANOUS GLOMERULONEPHRITIS ASSOCIATED WITH HEPATITIS C VIRUS INFECTION IN RENAL TRANSPLANT PATIENTS1,2. Transplantation. 63(11). 1634–1639. 109 indexed citations
12.
Loinaz, Carmelo, J.R. de Juanes, E. Moreno González, et al.. (1997). Hepatitis B vaccination results in 140 liver transplant recipients.. PubMed. 44(13). 235–8. 84 indexed citations
13.
Fernández, Inmaculada, et al.. (1997). Influence of Viral Genotype and Level of Viremia on the Severity of Liver Injury and the Response to Interferon Therapy in Spanish Patients with Chronic C Infection. Scandinavian Journal of Gastroenterology. 32(1). 70–76. 26 indexed citations
14.
Lumbreras, Carlos, et al.. (1997). [Use of DNA sequence hybridization with specific oligonucleotide probes to identify hepatitis C virus genotypes].. PubMed. 14(7). 433–5. 5 indexed citations
15.
Loffeld, R. J. L. F., B. F. M. Werdmuller, H Kordecki, et al.. (1996). 1C: Non-gastric diseases related to H. pylori infections. Gut. 39(Suppl 2). A89–A95. 2 indexed citations
16.
Loinaz, Carmelo, Carlos Lumbreras, I González-Pinto, et al.. (1995). High incidence of posttransplant hepatitis and chronic rejection associated with hepatitis C virus infection in liver transplant recipients.. PubMed. 27(1). 1217–8. 8 indexed citations
17.
Lumbreras, Carlos, Rafaël Delgado, A Fuertes, et al.. (1994). Clinical significance of hepatitis C virus (HCV) infection in liver transplant recipients. Digestive Diseases and Sciences. 39(5). 965–969. 9 indexed citations
18.
Lumbreras, Carlos, J. M. Aguado, Manuel Lizasoaín, et al.. (1992). [Prospective study of cytomegalovirus infection in liver transplant recipients].. PubMed. 99(11). 401–5. 5 indexed citations
19.
Castellano, Giancarlo, et al.. (1992). Clinical implications of the presence of antibodies to hepatitis C after renal transplantation.. PubMed. 24(1). 78–80. 5 indexed citations
20.
León, P., et al.. (1991). Characterization of HBV2‐like infections in Spain. Journal of Medical Virology. 33(4). 240–247. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Fretz Breakdown of academic impact, for papers by Hugo Wéclawiak Breakdown of academic impact, for papers by Michael I. Abecassis Breakdown of academic impact, for papers by Ingrid Keur Breakdown of academic impact, for papers by Ellen Holter Breakdown of academic impact, for papers by J. Rakela Breakdown of academic impact, for papers by Marc Deschênes Breakdown of academic impact, for papers by S. Tamura Breakdown of academic impact, for papers by Anthony I. Sahyoun Breakdown of academic impact, for papers by Nancy L. Ascher
Rankless by CCL
2026